Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Providers
February 07, 2020 02:42 PM

Addiction therapy meds barely used in residential treatment facilities

Steven Ross Johnson
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Getty Images
    Buprenorphine is used as an alternative to methadone to help addicts recovering from heroin use.

    Most residential treatment facilities do not provide patients with medications considered to be the 'gold standard' for treating opioid addiction, according to a new study.

    The analysis, published Friday in JAMA Network Open, found approximately 60% of the more than 2,860 residential facilities examined did not offer any medications approved by the U.S. Food and Drug Administration for treating opioid use disorder in 2017.

    The study examined federal survey data that included more than 232,000 admissions to residential treatment centers in 2017 and found opioid use disorder treatment medications were used for only 15% of patients at those facilities.

    "The majority are not offering medication to treat opioid use disorder, and when you look at whose being prescribed it is grossly underutilized," said study lead author Andrew Huhn, assistant professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine.

    Approximately 17% of patients admitted to residential facilities located in states that expanded Medicaid received medications compared to just 2% of patients in facilities located in non-expansion states.

    The disparity in access to opioid use disorder medications between Medicaid expansion and non-expansion states highlights the importance the program plays in addressing the impact of the opioid crisis, according to Dr. Yngvild Olsen, vice president of the board of directors for the Americans Society of Addiction Medicine.

    Olsen expressed concern over the potential impact of guidance released last month by the CMS that would allow states to apply for Section 1115 waivers to participate in the agency's Healthy Adult Opportunity initiative. Under the demonstration, states would expand Medicaid coverage to adults if they agreed to a per capita limit on funding for the program.

    Olsen worries that limitations to Medicaid funding will reduce access to treatment and result in more overdose deaths.

    A January report from the Centers for Disease Control and Prevention found more than 68,000 people died in 2018 from drug overdose despite a 4% decline in mortality compared to 2017.

    Opioids, which include prescription painkillers, heroin and fentanyl, remain the leading cause for overdose death. Those drugs resulted in a combined mortality rate of 18.4 deaths for every 100,000 people in 2018.

    The study's findings have huge implications for explaining why the use of medications for addiction treatment has remained low despite the impact of the opioid crisis.

    The use of medications such as buprenorphine and methadone along with psychosocial counseling is considered by medical professionals to be the 'gold standard' of addiction treatment.

    A study published Wednesday in JAMA Network Open found that between 2015 and 2017, treatment for opioid use disorder with buprenorphine and methadone was associated with a 76% reduction in overdose after three months and a 58% reduction in overdose after 12 months. By contrast, abstinence-based therapies such as detoxification, intensive behavioral health, and naltrexone treatment were not associated with a reduction in overdoses.

    Yet that study also found that those medications were vastly underused, with only 12.5% receiving MAT.

    The low use of medication within residential facilities highlights an ongoing philosophical debate within the addiction treatment community over the use of medications.

    Huhn said stigma could prevent policymakers and some treatment providers from addressing addiction as a chronic brain disease rather than a personal failing.

    "A lot of the infrastructure for addiction medicine was built apart from mainstream medicine," Huhn said. "A lot of it still revolves around 12-step philosophy, which is not at odds with using medication for opioid use disorder, but I think it gets misinterpreted."

    Both Huhn and Olsen suggested increasing MAT use could be done by eliminating federal regulations that require buprenorphine to be distributed by an opioid treatment program, or by doing away with prior authorization requirements for the drug by health insurers.

    Huhn and Olsen also agreed increasing licensure and accreditation requirements for addiction treatment facilities could be a useful way of promoting greater use of MAT. Huhn's study found treatment facilities that were licensed by a hospital or state authority or being accredited by a health organization were more likely to offer medications as part of their opioid use disorder treatment.

    "That certainly is one effective way that states and other policymakers can help move this area forward in terms of adoption of evidence-based care," Olsen said.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    diversity
    Health equity execs leveraging academic roles to drive long-term change
    Patrick Blair InnovAge
    PACE could expand amid possible nursing home closures: InnovAge CEO
    Most Popular
    1
    Centene to lay off 2,000 workers
    2
    How health systems are battling price-gouging allegations
    3
    Senate advances bill to temporarily aid hospitals, health centers
    4
    Elevance, Blue Cross Louisiana halt $2.5B proposed deal
    5
    Tower Health to sell urgent care centers, close others
    Sponsored Content
    Modern Healthcare A.M. Newsletter: Sign up to receive a comprehensive weekday morning newsletter designed for busy healthcare executives who need the latest and most important healthcare news and analysis.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing